Supporting Earlier Diagnosis of Skin Cancer

The East of England Cancer Alliance has worked with NHS organisations across the region to support the adoption of teledermatology services, helping to improve access to specialist skin cancer assessment and support earlier diagnosis.

Teledermatology enables high-quality images of skin lesions to be captured and securely shared with specialist clinicians for review. This allows patients to receive expert assessment more quickly, often without the need for an initial face-to-face outpatient appointment.

The approach supports faster clinical decision-making, helps ensure patients are directed to the most appropriate pathway and can reduce unnecessary hospital visits, while maintaining high standards of care.

Why Teledermatology Matters

Skin cancer is one of the most common cancers in England and referrals for suspected skin cancer continue to increase each year.

Earlier diagnosis of skin cancer, including melanoma, significantly improves treatment options and patient outcomes. Teledermatology can help ensure that patients with concerning lesions are identified and prioritised for specialist assessment and treatment as quickly as possible.

The use of digital imaging and remote specialist review also supports more efficient use of NHS resources and helps improve access to expertise across both rural and urban communities.

Innovation Across the East of England

The East of England Cancer Alliance has supported the implementation and expansion of teledermatology pathways across the region, working with healthcare providers, commissioners, clinicians and innovation partners.

This work has included supporting NHS organisations to adopt new digital technologies and diagnostic approaches that improve the assessment and management of patients with suspected skin cancer.

A range of teledermatology solutions are now being used across the NHS, including technologies that support:

  • Digital image capture and sharing.
  • Specialist remote review.
  • Artificial intelligence-assisted assessment and triage.
  • Faster referral and diagnostic pathways.
  • Improved patient access to specialist advice.

The Alliance's role has been to support the evaluation, implementation and spread of innovations that demonstrate the potential to improve patient outcomes and service delivery.

Supporting Innovation and Evaluation

The East of England Cancer Alliance has worked with national and regional partners to support the evaluation of innovative technologies that may enhance skin cancer pathways.

This includes participation in programmes supported through SBRI Healthcare, Health Innovation East, NHS England and industry partnerships, helping generate evidence on the role that emerging technologies, including artificial intelligence and digital diagnostics, can play in supporting earlier diagnosis and improving service efficiency.

By supporting real-world evaluation and adoption, the Alliance helps ensure that innovation is implemented safely, effectively and in a way that delivers meaningful benefits for patients and healthcare services.

National Developments

Teledermatology forms an important part of wider NHS efforts to improve cancer diagnosis and access to specialist care.

The NHS has invested in high-resolution imaging and digital dermatology technologies to increase diagnostic capacity, support faster assessment of skin lesions and improve access to specialist expertise across England.

The East of England Cancer Alliance continues to work closely with NHS England, providers and innovation partners to support the development and adoption of technologies that can improve skin cancer services across the region.

Working Together to Improve Skin Cancer Outcomes

Our teledermatology programme supports the ambitions of the East of England Cancer Alliance Strategy, the National Cancer Plan for England and the NHS 10 Year Health Plan by:

  • Supporting earlier diagnosis of skin cancer.
  • Improving patient access and experience.
  • Reducing variation and inequalities in care.
  • Increasing diagnostic capacity.
  • Enabling digital transformation and innovation.
  • Supporting more sustainable cancer services.

Through partnership working and innovation, we are helping ensure that patients across the East of England can benefit from faster access to specialist assessment and earlier diagnosis of skin cancer.

Further Information